Skip to main content

Research at Alzheimer Society of Canada

1-855-705-4636
  • Find a Research Study
  • FAQs
  • Legal Disclaimer
  • Contact Us
  • Français

Alzheimer Society of Canada

Find a Research Study

Bridge2AI-Voice as a Biomarker of Health

What is this Study about?

The human voice is unique to each individual and contains features that have been linked to diseases such as Parkinson's, mood disorders, and certain cancers. There is an increased interest in using voice in the diagnosis of disease, however current databases are limited in size. The main purpose of the Bridge2AI study is to build a large open science database of human voices, speech and respiratory sounds, other health data, and associated metadata that can be used to fuel artificial intelligence research related to voice. The neurological cohort aims to record speech data of patients with neurological and neurodegenerative conditions.

What Will Happen in This Study?

This study will take place at Mount Sinai Hospital in Toronto, Ontario, Canada. You will be asked to complete a variety of cognitive tests and questionnaires, will have your voice, speech, and respiratory sound data collected, and will be given the Montreal Cognitive Assessment. The whole process for one voice data collection session will take from 75-120 minutes to complete. There is an optional longitudinal study, which includes an additional 3 voice data collection sessions, each taking approximately 75 minutes. There is also an optional genomic study which includes the one-time collection of a small blood sample for whole genome sequencing and blood biomarker analysis.

Who is Eligible to Participate in this Study?

  • Between ages of 44-85
  • Able to read, write, speak, and understand English
  • Be diagnosed with one of the following conditions:
    • Alzheimer’s disease
    • Parkinson’s disease
    • Amyotrophic Lateral Sclerosis
    • Mild Cognitive Impairment, or other types of dementia
  • Consent to provide a voice/speech sample
Get in Touch About this Study

Legal Disclaimer

Any materials or links provided herein are strictly for informational purposes only. The Alzheimer Society of Canada does not endorse nor recommend any of the manufacturers, products or institutions mentioned in any of these links or listings as suitable or appropriate for your particular situation or circumstances and disclaims any liability with respect to representations, warranties, including fitness for an intended particular use or purpose, and all other claims relating thereto, all of which remain strictly with the manufacturer or institution.

In no event shall the Alzheimer Society of Canada or any third parties mentioned on the website be liable for any damage (including, without limitation, incidental and consequential damages for personal injury/wrongful death, lost profits or damages resulting from lost data or business interruption) or personal injury (including death) resulting from the use, misuse or inability to use any activity, product or service mentioned herein, whether based in warranty, contract, tort or any other legal theory.

Everyone considering participating in any activity is encouraged to speak with their own doctor or health-care team before participating in any activity that may impact their health or well-being.

Observational Study

Target Population

Person living with dementia, Person living with Alzheimer’s disease, Person living with mild cognitive impairment, Person living with Parkinson’s disease dementia

Target Age Group(s)

41-65, 66+

Study Location

In-Person

Toronto, Mount Sinai Hospital

Ontario

Study Contact

Madeleine Zanin
Research Assistant
Mount Sinai Health System

Recruitment Start Date

October 11, 2024

Recruitment End Date

December 31, 2026
  • Learn more about observational studies
  • Learn more about clinical trials
  • Brain donations
  • More useful links and resources

Alzheimer Society of Canada logo

Alzheimer Society of Canada
20 Eglinton Avenue West, 16th Floor
Toronto, Ontario M4R 1K8
Information and Referral Line: 1-855-705-4636
Email: [email protected]

Charity registration number: 11878 4925 RR0001

Follow us:

  • Find us on Facebook
  • Follow us on Twitter
  • Follow us on Instagram
  • Subscribe to us on YouTube
  • Find us in LinkedIn

©2022 Alzheimer Society of Canada. All rights reserved.